Cargando…

Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16

Forty cultured human leukemia and lymphoma cell lines never exposed to anticancer agents in culture, apart from doxorubicin (ADM)‐resistant K562/ADM, were examined for reactivity with a monoclonal antibody, MRK16 in F(ab′)(2) form [MRK16‐F(ab′)(2)], which recognizes P‐glycoprotein (P‐gp). The relati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Yasushi, Ohtsu, Tomoko, Hamada, Hirofumi, Sugimoto, Yoshikazu, Tobinai, Kensei, Minato, Keisuke, Tsuruo, Takashi, Shimoyama, Masanori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917883/ https://www.ncbi.nlm.nih.gov/pubmed/2575608 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01641.x

Ejemplares similares

A Novel Multidrug Resistance in Cultured Leukemia and Lymphoma Cells Detected by a Monoclonal Antibody to 85‐kDa Protein, MRK20
por: Ohtsu, Tomoko, et al.
Publicado: (1989)

Specialized Localization of P‐Glycoprotein Recognized by MRK 16 Monoclonal Antibody in Endothelial Cells of the Brain and the Spinal Cord
por: Sugawara, Isamu, et al.
Publicado: (1990)

High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas.
por: Sugawara, I., et al.
Publicado: (1989)

Further Characterization of the Human Adrenal‐derived P‐GIycoprotein Recognized by Monoclonal Antibody MRK 16 Reacting with Only Human P‐Glycoprotein
por: Sugawara, Isamu, et al.
Publicado: (1989)

Cellular and Tissue Distribution of MRK20 Murine Monoclonal Antibody‐defined 85‐kDa Protein in Adriamycin‐resistant Cancer Cell Lines
por: Sugawara, Isamu, et al.
Publicado: (1988)

Enhancement of Reversing Effect of Cyclosporin A on Vincristine Resistance by Anti‐P‐glycoprotein Monoclonal Antibody MRK‐16
por: Naito, Mikihiko, et al.
Publicado: (1993)

Anti-MrkA Monoclonal Antibodies Reveal Distinct Structural and Antigenic Features of MrkA
por: Wang, Qun, et al.
Publicado: (2017)

Inhibition of Multidrug‐resistant Human Tumor Growth in Athymic Mice by Anti‐P‐glycoprotein Monoclonal Antibodies
por: Tsuruo, Takashi, et al.
Publicado: (1989)

Expression Behavior of 85‐kDa Membrane Protein in Adriamycin‐resistant Tumor Cells and the Inhibition of Human Tumor Growth in Athymic Mice by MRK‐20 Monoclonal Antibody against the Protein
por: Ishii, Shigetaka, et al.
Publicado: (1993)

Monoclonal Anti‐P‐glycoprotein Antibody‐dependent Killing of Multidrug‐resistant Tumor Cells by Human Mononuclear Cells
por: Heike, Yuji, et al.
Publicado: (1990)

Observations of Mrk 421 with the MAGIC Telescope
por: Mazin, D
Publicado: (2005)

Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells
por: Ishida, Yasushi, et al.
Publicado: (1990)

Additional regulatory activities of MrkH for the transcriptional expression of the Klebsiella pneumoniae mrk genes: Antagonist of H-NS and repressor
por: Ares, Miguel A., et al.
Publicado: (2017)

Estrone and 17β‐Estradiol Reverse Breast Cancer Resistance Protein‐mediated Multidrug Resistance
por: Imai, Yasuo, et al.
Publicado: (2002)

Combination Therapy with Antibody and Interleukin–2 Gene Transfer against Multidrug–resistant Cancer Cells
por: Shinohara, Tsutomu, et al.
Publicado: (1997)

Transcriptional Activation of the mrkA Promoter of the Klebsiella pneumoniae Type 3 Fimbrial Operon by the c-di-GMP-Dependent MrkH Protein
por: Yang, Ji, et al.
Publicado: (2013)

Association between Presence of RmpA, MrkA and MrkD Genes and Antibiotic Resistance in Clinical Klebsiella pneumoniae Isolates from Hospitals in Tehran, Iran
por: Bakhtiari, Ronak, et al.
Publicado: (2021)

New Flow Cytometric Method for Detection of Minimally Expressed Multidrug Resistance P‐Glycoprotein on Normal and Acute Leukemia Cells Using Biotinylated MRK16 and Streptavidin‐RED670 Conjugate
por: Takeshita, Akihiro, et al.
Publicado: (1995)

Simultaneous Multi-wavelength Variability of the TeV Blazar Mrk 421
por: Gupta, A C
Publicado: (2005)

Molecular basis for isoform-selective inhibition of presenilin-1 by MRK-560
por: Guo, Xuefei, et al.
Publicado: (2022)

Mouse‐Human Chimeric Antibody MH171 against the Multidrug Transporter P‐Glycoprotein
por: Ariyoshi, Keiko, et al.
Publicado: (1992)

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
por: Tobinai, Kensei, et al.
Publicado: (2012)

A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies
por: Tobinai, Kensei, et al.
Publicado: (2016)

Regulation of cilium length and intraflagellar transport by the MAP kinases MAK, MRK, and MOK
por: Jansen, G, et al.
Publicado: (2012)

Effector Cell Analysis of Human Multidrug‐resistant Cell Killing by Mouse‐Human Chimeric Antibody against P‐Glycoprotein
por: Nishioka, Yasuhiko, et al.
Publicado: (1992)

Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
por: Makita, Shinichi, et al.
Publicado: (2020)

Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein
por: Vahedi, Shahrooz, et al.
Publicado: (2018)

The PilZ domain of MrkH represents a novel DNA binding motif
por: Wang, Feng, et al.
Publicado: (2016)

Safety profile of brentuximab vedotin in Japanese patients with relapsed/refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma: a post-marketing surveillance study
por: Izutsu, Koji, et al.
Publicado: (2021)

MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY
por: Tsuruo, Takashi
Publicado: (1988)

Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma
por: Makita, Shinichi, et al.
Publicado: (2017)

Expression of P‐Glycoprotein mRNA in Human Gastric Tumors
por: Sugimoto, Yoshikazu, et al.
Publicado: (1989)

Novel Insights into MSK1 Phosphorylation by MRKβ in Intracerebral Hemorrhage-Induced Neuronal Apoptosis
por: Gong, Peipei, et al.
Publicado: (2019)

A Review of New Findings in Adult T-cell Leukemia–Lymphoma: A Focus on Current and Emerging Treatment Strategies
por: Hermine, Olivier, et al.
Publicado: (2018)

Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin‐resistant Subline of Human Colon Carcinoma
por: Yanase, Kae, et al.
Publicado: (2000)

Oral histone deacetylase inhibitor HBI-8000 (tucidinostat) in Japanese patients with relapsed or refractory non-Hodgkin’s lymphoma: phase I safety and efficacy
por: Yoshimitsu, Makoto, et al.
Publicado: (2022)

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
por: Makita, Shinichi, et al.
Publicado: (2019)

Genetic Alteration of p53 in Some Patients with Adult T‐Cell Leukemia
por: Nagai, Hirokazu, et al.
Publicado: (1991)

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2017)

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma
por: Tsutsué, Saaya, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fscmlog4588qu4eob7o1t0663r